CAITLIN YOUNG: Open Payments
NPI 1669989000 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 92 payments from 20 companies in 2025. Trend: 2023 $1,818 · 2024 $1,541 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $223 |
| PFIZER INC. | 12 | $210 |
| Novo Nordisk Inc | 15 | $204 |
| ABBVIE INC. | 11 | $165 |
| Axsome Therapeutics, Inc. | 3 | $93 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Dexcom, Inc. | 5 | $81 |
| Astellas Pharma US Inc | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
Products named: ELIQUIS, Auvelity, QULIPTA, Ozempic, PREVNAR 20, Dexcom G6 Transmitter, Veozah, MOUNJARO.
Industry payments across GA — which companies pay providers there.
